Je was op zoek naar: malinja (Maltees - Engels)

- terapija intraplewrika ta ’ effużjoni plewrika malinja.
- intrapleural therapy of malignant pleural effusion.

alimta żied fit-tul tal-ħajja tal-pazjenti b’mesoteljoma plewrika malinja.
alimta increased the survival time of patients with malignant pleural mesothelioma.

alimta żied iż- żmien ta 'sopravivenza ta' pazjenti li jbatu minn mesoteljoma plewrika malinja.
alimta increased the survival time of patients with malignant pleural mesothelioma.

għandek tinforma lit- tabib tiegħek jekk għandek xi kundizzjoni( jiet) malinja (/ i)
you should inform your doctor if you have any malignant condition(s).

il- potenzjal għall- immunosuppressjoni lokali (li aktarx toħloq infezzjonijiet jew ġilda malinja) ma od
in the presence of these infections, the balance of risks and benefits associated with protopy use should be evaluated. a

it- tliet studji ewlenin l- oħra involvew pazjenti bi glijoma malinja li reġgħet feġġet jew li saret agħar wara l- kura li kienu diġà ħadu.
the other three main studies involved patients with malignant glioma that had come back or got worse after previous treatment.

għat- trattament ta 'mesoteljoma plewrika malinja, alimta ġie studjat fi studju ewlieni fuq 456 pazjent li ma kinux irċevew kemjoterapija għall- marda tagħhom qabel.
for the treatment of malignant pleural mesothelioma, alimta has been studied in one main study in 456 patients who had not received chemotherapy for their disease before.

il-potenzjal għall-immunosuppressjoni lokali (li aktarx toħloq infezzjonijiet jew ġilda malinja) ma nafux x’inhu meta jgħaddi ħafna żmien (ngħidu aħna wara perijodu ta’ snin) (ara sezzjoni 5.1).
the potential for local immunosuppression (possibly resulting in infections or cutaneous malignancies) in the long term (i.e. over a period of years) is unknown (see section 5.1).